Success Stories: In Just 6 Months and that too without an RFE, Our Team Wins NIW Approval for a Senior Scientist in Molecular Biology from Bangladesh

Posted by wegreened on January 5, 2023 in NIW, Biology (Pathology and Immunology, Human Genetics, Genomics, Molecular Biology, Animal, Plant, Microbiology, Genetics, Botany)

Client’s Testimonial:

“It has been a real pleasure working with Chen Law Firm. I appreciate the support. I will certainly refer my Friends to Chen Law Firm for NIW petition filing.”

On April 19^th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Senior Scientist in the Field of Molecular Biology (Approval Notice).

General Field: Molecular Biology

Position at the Time of Case Filing: Senior Scientist

Country of Origin: Bangladesh

State of Residence at the Time of Filing: Alabama

Approval Notice Date: April 19^th, 2022

Processing Time: 6 months

Case Summary:

An expert in the field of biomedical engineering from Bangladesh came to us seeking help with his NIW (National Interest Waiver). He was a Ph.D. in integrative bioscience and was working as a senior scientist at that time. His proposed endeavor was to continue his research on the production of novel, targeted drug delivery options for cancer immunotherapy that improve patient outcomes and cancer care standards .So, as soon as our team had signed the retainer agreement with him, they began investigating his academic and professional achievements. This helped them make an exhaustive list of his accomplishments, which were later used to write his petition for the USCIS. The list contained some of the following:

A detailed description of his proposed endeavor was first given to familiarize the adjudicating bench with the merits of his case.
We tried to show that his research advancing his proposed endeavor is of great importance because it improves our ability to treat many forms of cancer and prostate cancer in particular.
This is why he also obtained 4 letters recommending his work for the country and the world. Of these recommendations, one had the following passage:

“[Client’s] research has wider applications beyond the research sphere. Cancer is one of the leading causes of death in the United States, with over 600,000 people dying from the disease in 2020 alone. In addition to causing hundreds of thousands of deaths, the economic cost of cancer is exceedingly high... His development of the targeting peptide, which is a low-cost and effective antitumor treatment compatible with existing cancer treatments, is clearly beneficial to this goal. As such, his continued research is undoubtedly relevant to the national interest. The funding his work has received from the National Cancer Institute, the Department of Defense, and the National Institutes of Health further highlights the significance of this research to the United States.”

Furthermore, due to its clear national importance, his research has also been supported with funding from the National Institutes of Health, National Cancer Institute, NCI Cancer Research Center, National Center for Advancing Translational Sciences, Department of Defense, Rachel Guss and Bob Pomerenk Pancreas Cancer Research Fellowship.
At the same time, his work has resulted in 4 peer-reviewed journal articles and 2 peer-reviewed abstracts (1 of them first-authored).
We also noted that these publications have been cited a total of 109 times according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of molecular biology.

All of these facts helped us indicate successfully that his work was indeed valuable for the United States and thus should be allowed to continue. This won him the approval of the adjudication committee in 6 months only.

We are glad to have worked with him and we wish him all the best in his future endeavors.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%